NCT06088914

Brief Summary

The goal of this phase I/II clinical trial is to determine the behavioral and neural effects of 5-daily transcranial direct current stimulation on post-stroke fatigue. The three aims are: Aim 1: Investigate the behavioral effect of 5 daily sessions of anodal tDCS over the ipsilesional M1 on PSF. Aim 2: Investigate the neurophysiological effect of 5 daily sessions of anodal tDCS over the ipsilesional M1. Aim 3: Determine the relationship between changes in M1 excitability, brain connectivity and changes in PSF. Participants will receive either a real or sham stimulation for 5 consecutive days and fatigue will be assessed before, immediately after and 1-month after the intervention. Fatigue will be assessed using clinical, behavioral, and neurophysiological outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
4mo left

Started Dec 2023

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Dec 2023Aug 2026

First Submitted

Initial submission to the registry

September 18, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

December 15, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

October 16, 2024

Status Verified

October 1, 2024

Enrollment Period

2.7 years

First QC Date

September 18, 2023

Last Update Submit

October 14, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Fatigue Severity Scale score

    This is a 9 item questionnaire and each item is rated on a Likert scale 1-7. Participants will rate their responseS based on their previous week experience. A higher score suggests more fatigue.

    This outcome will be assessed at 3 time points during the study, at baseline, immediately after the intervention ( an average of 7 days from baseline) and at follow-up (an average of 5 weeks from baseline)

  • Input-output curve slope

    Brain excitability will be indexed using the input-output curve slope acquired with single-pulse transcranial magnetic stimulation (TMS)protocol. A greater slope value indicates a greater brain excitability.

    This outcome will be assessed at 3 time points during the study, at baseline, immediately after the intervention ( an average of 7 days from baseline) and at follow-up (an average of 5 weeks from baseline)

Secondary Outcomes (6)

  • Borg Rating of Perceived Exertion

    This outcome will be assessed at 3 time points during the study, at baseline, immediately after the intervention ( an average of 7 days from baseline) and at follow-up (an average of 5 weeks from baseline)

  • Functional connectivity of the fronto-striato-thalamic network

    This outcome will be assessed at 2 time points during the study, at baseline and immediately after the intervention ( an average of 7 days from baseline).

  • Fatigue Scale for Motor and Cognitive Function

    This outcome will be assessed at 3 time points during the study, at baseline, immediately after the intervention ( an average of 7 days from baseline) and at follow-up (an average of 5 weeks from baseline)

  • Visual Analog Scale-Fatigue

    This outcome will be assessed at 3 time points during the study, at baseline, immediately after the intervention ( an average of 7 days from baseline) and at follow-up (an average of 5 weeks from baseline)

  • Paas Mental Effort Rating Scale

    This outcome will be assessed at 3 time points during the study, at baseline, immediately after the intervention ( an average of 7 days from baseline) and at follow-up (an average of 5 weeks from baseline)

  • +1 more secondary outcomes

Other Outcomes (4)

  • Functional connectivity of other established brain networks.

    This outcome will be assessed at 2 time points during the study, at baseline and immediately after the intervention ( an average of 7 days from baseline).

  • Reach movement time

    This outcome will be assessed at 3 time points during the study, at baseline, immediately after the intervention ( an average of 7 days from baseline) and at follow-up (an average of 5 weeks from baseline)

  • Reach reaction time

    This outcome will be assessed at 3 time points during the study, at baseline, immediately after the intervention ( an average of 7 days from baseline) and at follow-up (an average of 5 weeks from baseline)

  • +1 more other outcomes

Study Arms (2)

Anodal tDCS group

EXPERIMENTAL

Participants will receive anodal tDCS applied to the ipsilesional primary motor cortex.

Device: Anodal transcranial direct current stimulation

Sham tDCS

SHAM COMPARATOR

Participants will receive sham tDCS applied to the ipsilesional primary motor cortex

Device: Sham transcranial direct current stimulation

Interventions

Anodal tDCS will be delivered for 5 consecutive days. Participants will receive 2 mA of stimulation for 20 minutes with the anodal electrode placed on the ipsilesional primary motor cortex (M1) and the cathodal electrode placed over the contralateral supraorbital area.

Anodal tDCS group

Sham tDCS will be delivered for 5 consecutive days. Participants will receive sham stimulation for 20 minutes with the current intensity ramping down after 30 seconds of stimulation. The anodal electrode placed on the ipsilesional primary motor cortex (M1) and the cathodal electrode placed over the contralateral supraorbital area.

Sham tDCS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be at least 18 years old;
  • have a history of unilateral stroke ≥ 3 months prior to enrollment to ensure stability;
  • have an average score ≥ 4 on FSS;
  • have some movement capability in the more affected arm (upper extremity Fugl-Meyer(FMUE) ≥ 28) to ensure they can perform the reaching task;
  • be able to follow three-step commands.

You may not qualify if:

  • acute medical problems;
  • the presence of any contraindication to tDCS, MRI or TMS;
  • the presence of significant depression (score \> 10 on the Patient Health Questionnaire-9);
  • significant pain in the upper extremities that interferes with movements; or
  • use of medication which may affect the level of fatigue.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Woman's University

Dallas, Texas, 75235, United States

RECRUITING

Related Publications (1)

  • Liao KC, Christian I, Stewart J, Trudelle-Jackson E, Wang W, Shang T, Goh HT. Behavioral and Neural correlates of Post-STROKE Fatigue: A randomized controlled trial protocol. PLoS One. 2025 Jun 6;20(6):e0324591. doi: 10.1371/journal.pone.0324591. eCollection 2025.

MeSH Terms

Conditions

StrokeFatigue

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Hui-Ting Goh

    Physical Therapy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hui-Ting Goh

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2023

First Posted

October 18, 2023

Study Start

December 15, 2023

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

October 16, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

Upon publication of the manuscripts, the de-identified data generated from the project will be made available to qualified researchers outside our research team upon request. The investigators will also deposit the de-identified data to the NICHD Data and Specimen Hub (DASH).

Shared Documents
STUDY PROTOCOL
Time Frame
Upon the publication of the manuscripts (\~12 months after study completion).
Access Criteria
Qualified researchers can contact PI via email (hgoh1@twu.edu) to request access to the de-identified data. DASH users can request access to the de-identified data deposited to the NICH DASH.

Locations